Добро пожаловать
Нажатие «Авторизоваться» означает, что вы соглашаетесь с Условия использования и политика конфиденциальности Cointime.
Зарегистрировать аккаунт
Аккаунт уже существует?
Нажатие «page.Sign up» означает, что вы соглашаетесь с <a class="underline" href="#term-of-service">Условия использования</a> и a class="underline" href="#privacy-policy">политика конфиденциальности</a> Cointime.
Войдите, используя email
Зарегистрируйтесь с помощью email
твой почтовый ящик
Проверь свои входящие
Нажмите на ссылку в , чтобы войти.
Нажмите на ссылку в , чтобы зарегистрироваться.
Apogee Therapeutics
company
About
Apogee Therapeutics is a biotechnology company that offers therapies for immunological and inflammatory disorders.
- San Francisco,California,United States
- 1 - 10
- https://apogeetherapeutics.com/
Details
- Last Funding Type
- Series A
- Last Funding Money Raised
- $20M
- Industries
- Biotechnology,Life Science,Medical,Therapeutics
- Founded date
- Jan 1, 2022
- Number Of Employee
- 1 - 10
- Operating Status
- Active
- Legal Name
- Apogee Therapeutics, Inc.
Apogee Therapeutics is a biotechnology company that offers therapies for immunological and inflammatory disorders. The company aims to advance novel therapies to address patients’ needs. Based in San Francisco, California, Apogee Therapeutics was founded in 2022.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
$169M
Apogee Therapeutics has raised a total of
$169M
in funding over 2 rounds. Their latest funding was raised on
Dec 7, 2022 from a Series B round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Dec 7, 2022 | Series B | $149M | 9 |
Deep Track Capital
RTW Investments
|
— | Detail |
| Jan 1, 2022 | Series A | $20M | 2 |
Fairmount Funds Management
|
— | Detail |
Investments
Number of Investments
Number of Lead Investments
10
1
Apogee Therapeutics has made 10 investments. Their most recent investment was on
Nov 15, 2022, when EngFlow raised $18M.
|
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
|---|---|---|---|---|
|
Nov 15, 2022
EngFlow
|
Series A | $18M | Cloud Computing | — |
|
Nov 2, 2022
Gitpod
|
Series A | $25M | Developer Platform | Yes |
|
Dec 28, 2021
Ready Player Me
|
Series A | $13M | 3D Technology | — |
|
Oct 28, 2021
Cover
|
Series B | $60M | Building Material | — |
|
Sep 15, 2021
Replay
|
Pre-seed | $3.10M | Developer Tools | — |
Investors
Number of Lead Investors
Number of Investors
4
9
Apogee Therapeutics is funded by 9 investors.
Deep Track Capital
and RTW Investments
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Deep Track Capital
|
Yes | Series B |
|
RTW Investments
|
Yes | Series B |
|
Fairmount Funds Management
|
— | Series B |
Fidelity Management and Research Company
|
— | Series B |
OrbiMed
|
— | Series B |
Perceptive Advisors
|
— | Series B |
RA Capital Management
|
— | Series B |
|
|
— | Series B |
Wellington Management
|
— | Series B |
Employee Profiles
Number of Employee Profiles
2
Apogee Therapeutics has 2 current employee profiles, including
Executive Michael Henderson
Executive
Board member
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
